Evidence map›Paper›PMID 39873780›Full record

ReviewInternational urogynecology journal2025

International Urogynecology Consultation Chapter 3 Committee 1 - Pessary Management.

Angie Rantell, Zeelha Abdool, Morgan E Fullerton, Abel Gedefaw, Kate Lough, Pawel Miotla, Narmin Mukhtarova, Patricia Neumann, Jordan Spencer, Kristina J Warner and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Review
  4. Article
  5. Diagnosis and management of urinary incontinence in females.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Angie RantellKing's College Hospital & Brunel University, London, UK. angela.rantell@nhs.net.
Zeelha AbdoolObstetrics & Gynaecology, University of Pretoria, Pretoria, South Africa.
Morgan E FullertonDivision of Urogynecology, Department of Obstetrics and Gynecology, Kaiser Permanente, Panorama City, CA, USA.
Abel GedefawCollege of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.
Kate LoughGreater Glasgow and Clyde NHS, Glasgow, Scotland.
Pawel MiotlaDepartment of Gynecology, Medical University of Lublin, Lublin, Poland.
Narmin MukhtarovaDepartment of Pediatrics, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Patricia NeumannUniversity of South Australia, Adelaide, Australia.
Jordan SpencerLouisiana State University in Baton Rouge LA, Baton Rouge, LA, USA.
Kristina J WarnerUniversity of Wisconsin Unity Point Meriter Hospital, Madison, WI, USA.
Heidi W BrownDivision of Health Services Research & Implementation Science, Southern California Permanente Medical Group, San Diego, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisThis manuscript is part of the International Urogynecological Consultation (IUC) on Pelvic Organ Prolapse (POP), Chapter 3, Committee 1 focusing on pessary management of POP.

methodsA narrative review was conducted by an international, multi-disciplinary group of clinicians working in the field of pelvic health following a search of the literature using the MeSH terms "pelvic organ prolapse" OR "urogenital prolapse" OR "vaginal prolapse" OR "uterovaginal prolapse" AND "pessary" OR "support device" OR "intravaginal device." Relevant studies, as determined after review using the Covidence manuscript review platform, were included.

resultsA total of 540 articles were reviewed, of which 313 were included for this narrative review. The reported pessary fitting success rate ranges from 41% to 96.6%, and the continuation of successful use rate varied from 21% to 97.7%. The most likely predictors of unsuccessful fitting trials were previous POP surgery, previous hysterectomy, short vaginal length, wide genital hiatus, and posterior compartment involvement. Following successful pessary placement in individuals with POP, vaginal bulge and pressure resolved in over 90%. A significant improvement in obstructive voiding was reported in 40-97% of participants, urinary urgency in 38%, urgency urinary incontinence in 29-77%, and stress urinary incontinence in 9-45%. Older age and women who can self-manage the pessary care or had family support were factors associated with pessary continuation. Common reasons reported for discontinuation included expulsion, vaginal pain/discomfort, unwillingness to continue, erosions, desire for surgery, bleeding, symptoms not improved with pessary, and incontinence. More serious complications (fistula, bowel obstruction, pessary impaction, and vaginal cancer) are rare, and occur usually in older women in whom pessary maintenance has been neglected. There is no high-quality evidence to guide pessary choice. The current literature lacks studies specifically focused on determining the role of preventative measures, i.e., estrogen, pessary type/material as regards to pessary-associated complications (PACs). The review identified a lack of information about the relevant and required training and education (for healthcare professionals and patients) for pessary provision, use, and management.

conclusionsThere is a considerable body of published work on the use of pessaries for POP, including effectiveness, factors associated with success and failure, and complications. However, there is a dearth of published literature regarding how pessary types are selected by providers, how providers are trained, what defines competency in pessary provision, and what constitutes appropriate patient education related to pessary use and management.

Indexed as

Pelvic Organ ProlapsePessariesFemaleGynecologyHumansPelvic organ prolapsePessaryVaginal device

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.